revealed that combining MUC1-MBP with BCG stimulates a dual immune response, enhancing Th1-type immunity and the cytotoxic function of MUC1-specific CTLs, while also boosting NK cell activity, effectively inhibiting the growth of MUC1-positive tumor cells (164). The gene discussed is MBP; the disease is neoplasm.